Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003530110 | SCV004314307 | pathogenic | Hereditary breast ovarian cancer syndrome | 2023-08-05 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 631514). This premature translational stop signal has been observed in individual(s) with BRCA2-related conditions (PMID: 33754277). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser309Hisfs*15) in the BRCA2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BRCA2 are known to be pathogenic (PMID: 20104584). |
Department of Pathology and Laboratory Medicine, |
RCV005392371 | SCV006055109 | pathogenic | Familial cancer of breast; Breast-ovarian cancer, familial, susceptibility to, 2; Fanconi anemia complementation group D1; Medulloblastoma; Wilms tumor 1; Pancreatic cancer, susceptibility to, 2; Glioma susceptibility 3; Familial prostate cancer | 2020-06-23 | criteria provided, single submitter | clinical testing | |
Academic Center for Education, |
RCV000778088 | SCV000914183 | pathogenic | Familial cancer of breast | 2019-05-19 | no assertion criteria provided | clinical testing |